The influence of TXNDC5 gene on gastric cancer cell

Lin Zhang1, Yanhong Hou, Nan Li

  • 1Department of Gastroenterology and Hepatology, The 309 Hospital of PLA, Beijing 100091, China. stepinghuns@yahoo.com.cn

Abstract

Insights

Thioredoxin domain containing 5 (TXNDC5) promotes gastric cell growth, proliferation, and invasion. Silencing TXNDC5 restrains gastric cancer cell growth, indicating its role as a tumor-enhancing gene.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • TXNDC5 is over-expressed in various cancers, including gastric adenocarcinoma.
  • The specific functional roles of TXNDC5 in gastric cancer remain largely unknown.
  • This study investigates TXNDC5's impact on gastric cancer cell behavior.

Purpose of the Study:

  • To elucidate the functional significance of TXNDC5 in gastric adenocarcinoma.
  • To determine TXNDC5's effects on gastric cell growth, proliferation, apoptosis, invasion, and cell cycle.
  • To evaluate TXNDC5 as a potential therapeutic target in gastric cancer.

Main Methods:

  • TXNDC5 gene was overexpressed in normal gastric cells (HFE145) and silenced in gastric cancer cells (MKN45) using siRNA.
  • Cell growth, proliferation, apoptosis, cell cycle, and invasion were assessed.
  • Stable cell lines (HFE-TXNDC5 and MKN-SR1) were generated and compared to control groups.

Main Results:

  • Overexpression of TXNDC5 in HFE145 cells accelerated growth and proliferation.
  • Silencing TXNDC5 in MKN45 cells inhibited growth and proliferation.
  • TXNDC5 influenced cell cycle distribution and reduced apoptosis in normal cells.
  • TXNDC5 overexpression enhanced cell invasion, while silencing reduced it in cancer cells.

Conclusions:

  • TXNDC5 promotes gastric cell growth, proliferation, and invasion.
  • Silencing TXNDC5 inhibits gastric cancer cell progression.
  • TXNDC5 functions as a tumor-enhancing gene in gastric cancer.
  • Targeting TXNDC5 may offer a therapeutic strategy for gastric adenocarcinoma.

Related Concept Videos

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...